Table 5 Severity of dysmenorrhea assessed by VMS in two groups of study on the first day of the control cycle, the first intervention cycle, and the second intervention cycle
Time | Grade | Auriculotherapy group (n = 41) n(%) | Mefenamic acid group (n = 42) n(%) | P value (between groups) |
|---|---|---|---|---|
aControl cycle | 2 | 31 (75.6) | 32 (76.2) | 0.95 |
3 | 10 (24.4) | 10 (23.8) | ||
b1st cycle | 0 | 5 (12.2) | 4 (9.5) | 0.06 |
1 | 13 (31.7) | 10 (23.8) | ||
2 | 21 (51.2) | 17 (40.5) | ||
3 | 2 (4.9) | 11 (26.2) | ||
b2nd cycle | 0 | 7 (17.1) | 2 (4.8) | <0.001 |
1 | 20 (48.8) | 8 (19) | ||
2 | 14 (34.1) | 25 (59.5) | ||
3 | 0 (0) | 7 (16.7) | ||
cP value (within groups) | Â | < 0.001 | Â | 0.003 |